This post is sponsored by Biotheranostics, Inc. (Breast Cancer Index®). Thoughts and opinions are my own.

If you caught my last post a few weeks ago, you know I have partnered this year with the Breast Cancer Index. If you missed the first post, you can read it here.

As my journey getting to know the ins and outs of breast cancer treatment grows, the more hope I have found in not waiting another minute being fearful of recovery. Though I have not, yet, been diagnosed with breast cancer, I have had some close calls. Just being a woman puts me in a close call category all on its own.

A Message to Me (and You) About Breast Cancer

I have seen far too many of my friends suffer while recovering from breast cancer treatment and it’s simply heartbreaking. The ups and downs. The uncertainty. The fear. This is why I’m proud to partner with such a fabulous group who have dedicated their lives to a positive recovery.

Did you know that nearly 95% of women with early-stage, hormone receptor-positive (HR+) breast cancer do not benefit from anti-estrogen therapy beyond 5 years? 

Since approximately 3-5% of women do benefit from anti-estrogen therapy after 5 years, the Breast Cancer Index test could give women a reason to continue their therapy for 10 years to keep cancer from coming back. And for the women who do not benefit after 5 years, they will be able to have some peace of mind about discontinuing treatment.

A Message to Me (and You) About Breast Cancer

This is where the Breast Cancer Index comes in.


Breast Cancer Index (BCI) is a test that provides information to help women diagnosed with early-stage, hormone receptor-positive (HR+) breast cancer, and their oncologists make personalized decisions about extending anti-estrogen (also called hormonal or endocrine) therapy beyond 5 years. (Read Intended Use and limitations at

A Message to Me (and You) About Breast Cancer

Breast Cancer Index is a test that looks at your initial tumor sample to provide two pieces of information:

  1. Whether an additional 5 years of anti-estrogen therapy is likely to help reduce your risk of the cancer returning (recurrence) as metastatic disease
  2. Your individual risk of metastatic recurrence between 5 and 10 years after your initial diagnosis, which is presented as a percentage risk [e.g., 3.2% or 7.5%]

The maker of the Breast Cancer Index test created this video, which is simple, but yet so powerful. I hope you will take a few seconds to watch it.

Not. Another. Minute.

I will be sharing more about Breast Cancer Index with you in the coming weeks with you. Please check back in to support all women, both those who have been affected by breast cancer and those who haven’t. It’s important that we educate our sisters about their options.

In the meantime, learn more about the Breast Cancer Index by visiting and follow #notanotherminute on social media.

A Message to Me (and You) About Breast Cancer